-Network: (11 - Statement - Statement Of Financial Position Classified)

-Statement of Financial Position [Abstract] {ID1}

-Statement [Table] {ID2}

-Statement [Line Items] {ID3}

-ASSETS {ID4}

-Current assets: {ID5}

Cash and cash equivalents {ID6}

Patient accounts receivable, net of allowance for doubtful accounts of $30,806 and $27,052 {ID7}

Prepaid expenses {ID8}

Other current assets {ID9}

Total current assets {ID10}

Property and equipment, net of accumulated depreciation of $48,326 and $39,208 {ID11}

Goodwill {ID12}

Intangible assets, net of accumulated amortization of $9,487 and $7,944 {ID13}

Other assets, net {ID14}

Total assets {ID15}

-LIABILITIES AND EQUITY {ID16}

-Current liabilities: {ID17}

Accounts payable {ID18}

Accrued expenses {ID19}

Obligations due Medicare {ID20}

Current portion of long-term obligations {ID21}

Current portion of deferred income taxes {ID22}

Total current liabilities {ID23}

Long-term obligations, less current portion {ID24}

Deferred income taxes {ID25}

Other long-term obligations {ID26}

Total liabilities {ID27}

Commitments and Contingencies - Note 6 {ID28}

-Equity: {ID29}

Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding {ID30}

Common stock, $0.001 par value, 60,000,000 shares authorized; 27,830,092 and 27,191,946 shares issued; and 27,719,570 and 27,083,231 shares outstanding {ID31}

Additional paid-in capital {ID32}

Treasury stock at cost, 110,522 and 108,715 shares of common stock {ID33}

Accumulated other comprehensive loss {ID34}

Retained earnings {ID35}

Total Amedisys, Inc. stockholders' equity {ID36}

Noncontrolling interests {ID37}

Total equity {ID38}

Total liabilities and equity {ID39}

-Network: (12 - Statement - Statement Of Financial Position Classified (Parenthetical))

-Statement of Financial Position [Abstract] {ID40}

-Statement [Table] {ID41}

-Statement [Line Items] {ID42}

Patient accounts receivable, allowance for doubtful accounts {ID43}

Property and equipment, accumulated depreciation {ID44}

Intangible assets, accumulated amortization {ID45}

Preferred stock, par value {ID46}

Preferred stock, shares authorized {ID47}

Preferred stock, issued {ID48}

Preferred stock, outstanding {ID49}

Common stock, par value {ID50}

Common stock, shares authorized {ID51}

Common stock, shares issued {ID52}

Common stock, shares outstanding {ID53}

Treasury stock at cost, shares {ID54}

-Network: (13 - Statement - Statement Of Income Alternative)

-Income Statement [Abstract] {ID55}

-Statement [Table] {ID56}

-Statement [Line Items] {ID57}

Net service revenue {ID58}

Cost of service, excluding depreciation and amortization {ID59}

-General and administrative expenses: {ID60}

Salaries and benefits {ID61}

Non-cash compensation {ID62}

Other {ID63}

Provision for doubtful accounts {ID64}

Depreciation and amortization {ID65}

Operating expenses {ID66}

Operating income {ID67}

-Other (expense) income: {ID68}

Interest income {ID69}

Interest expense {ID70}

Miscellaneous, net {ID71}

Total other expense {ID72}

Income before income taxes {ID73}

Income tax expense {ID74}

Net income {ID75}

Net (income) loss attributable to noncontrolling interests {ID76}

Net income attributable to Amedisys, Inc. {ID77}

-Net income attributable to Amedisys, Inc. common stockholders: {ID78}

Basic {ID79}

Diluted {ID80}

-Weighted average shares outstanding: {ID81}

Basic {ID82}

Diluted {ID83}

-Network: (14 - Statement - Statement Of Cash Flows Indirect)

-Statement of Cash Flows [Abstract] {ID84}

-Statement [Table] {ID85}

-Statement [Line Items] {ID86}

-Cash Flows from Operating Activities: {ID87}

Net income {ID88}

-Adjustments to reconcile net income to net cash provided by operating activities: {ID89}

Depreciation and amortization {ID90}

Provision for doubtful accounts {ID91}

Non-cash compensation {ID92}

401(k) employer match {ID93}

Loss on disposal of property and equipment {ID94}

Deferred income taxes {ID95}

Write off of deferred debt issuance costs {ID96}

Equity in earnings of unconsolidated joint ventures {ID97}

Amortization of deferred debt issuance costs {ID98}

Return on equity investment {ID99}

-Changes in operating assets and liabilities, net of impact of acquisitions: {ID100}

Patient accounts receivable {ID101}

Other current assets {ID102}

Other assets {ID103}

Accounts payable {ID104}

Accrued expenses {ID105}

Other long-term obligations {ID106}

Net cash provided by operating activities {ID107}

-Cash Flows from Investing Activities: {ID108}

Proceeds from sale of deferred compensation plan assets {ID109}

Proceeds from the sale of property and equipment {ID110}

Purchases of deferred compensation plan assets {ID111}

Purchases of property and equipment {ID112}

Acquisitions of businesses, net of cash acquired {ID113}

Acquisitions of reacquired franchise rights {ID114}

Net cash (used in) investing activities {ID115}

-Cash Flows from Financing Activities: {ID116}

Outstanding checks in excess of bank balance {ID117}

Proceeds from issuance of stock upon exercise of stock options and warrants {ID118}

Proceeds from issuance of stock to employee stock purchase plan {ID119}

Tax benefit from stock option exercises {ID120}

Proceeds from Revolving Line of Credit {ID121}

Repayments of Revolving Line of Credit {ID122}

Proceeds from issuance of long-term obligations {ID123}

Payment of deferred financing fees {ID124}

Principal payments of long-term obligations {ID125}

Net cash (used in) provided by financing activities {ID126}

Net (decrease) in cash and cash equivalents {ID127}

Cash and cash equivalents at beginning of period {ID128}

Cash and cash equivalents at end of period {ID129}

-Supplemental Disclosures of Cash Flow Information: {ID130}

Cash paid for interest {ID131}

Cash paid for income taxes, net of refunds received {ID132}

-Supplemental Disclosures of Non-Cash Financing and Investing Activities: {ID133}

Notes payable issued for acquisitions {ID134}

Notes payable issued for software licenses {ID135}

AMEDISYS INC XBRL Taxonomy Presentation Networks